Yasuhiko Hattori

TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations

Hideyuki Arita, Yuko Matsushita, Ryunosuke Machida et al. · Acta Neuropathologica Communications · 2020 · 77 citations · Full text

Medicine, Genetics, Oncology +12

PD-L1 and PD-L2 expression in the tumor microenvironment including peritumoral tissue in primary central nervous system lymphoma

Motomasa Furuse, Hiroko Kuwabara, Naokado Ikeda et al. · BMC Cancer · 2020 · 46 citations · Full text

Medicine, Oncology, Pathology +17

Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration

Atsuhito Uneda, Kazuhiko Kurozumi, Atsushi Fujimura et al. · Acta Neuropathologica Communications · 2021 · 41 citations · Full text

Medicine, Cell Biology, Oncology +7

Spinal Cord Diffuse Midline Glioma, H3K27M- mutant Effectively Treated with Bevacizumab: A Report of Two Cases

Satoru Yabuno, Satoshi Kawauchi, Michiari Umakoshi et al. · NMC Case Report Journal · 2021 · 41 citations · Full text

Medicine, Neurosurgery, Oncology +17

Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion

Yoshihiro Otani, Tomotsugu Ichikawa, Kazuhiko Kurozumi et al. · Oncogene · 2017 · 40 citations

Medicine, Cancer Biology, Oncology +16